Apimeds Pharmaceuticals US (APUS) Debt Ratio (2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Debt Ratio came in at 0.96 in Q1 2025.
Apimeds Pharmaceuticals US (APUS) Debt Ratio (2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 1 years of Debt Ratio data on file, last reported at 0.96 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 0.12 |
| 10 | Apimeds Pharmaceuticals US | 7.35 Mn | 7.35 Mn | - | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.96 |